PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF

A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the compo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VERWIJS, MARINUS JACOBUS, ALARGOVA, ROSSITZA GUEORGUIEVA, KADIYALA, IRINA NIKOLAEVNA, KAUSHIK, RITU ROHIT, YOUNG, CHRISTOPHER RYAN
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	VERWIJS, MARINUS JACOBUS ALARGOVA, ROSSITZA GUEORGUIEVA KADIYALA, IRINA NIKOLAEVNA KAUSHIK, RITU ROHIT YOUNG, CHRISTOPHER RYAN
description	A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3150198TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3150198TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3150198TT33</originalsourceid><addsrcrecordid>eNqNjsFqAjEURWfjotj-Q9yN4IPOBMUuny8Z5kGSFzIRHEVESrqSVrCf1A9tLf2ALg53c7ich-or9pg8kt1mJnSKxEcZOLOEQUmnNNQrqBuo20ULhju3lSQbG_ZyMMdDs9BHw7ITB0sY3VzRSE5ikojBEqaN7NCzkTlo8Db3o4tjYjEcoL37v0dMComNwvCD8Rx4yAnvBSr3NlnpHqvJ2_lyK09_O61mnc3UQ7l-nMrten4t7-XzFJ1uls_Nyzpnrf_jfAM5qEYc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF</title><source>esp@cenet</source><creator>VERWIJS, MARINUS JACOBUS ; ALARGOVA, ROSSITZA GUEORGUIEVA ; KADIYALA, IRINA NIKOLAEVNA ; KAUSHIK, RITU ROHIT ; YOUNG, CHRISTOPHER RYAN</creator><creatorcontrib>VERWIJS, MARINUS JACOBUS ; ALARGOVA, ROSSITZA GUEORGUIEVA ; KADIYALA, IRINA NIKOLAEVNA ; KAUSHIK, RITU ROHIT ; YOUNG, CHRISTOPHER RYAN</creatorcontrib><description>A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220117&DB=EPODOC&CC=PL&NR=3150198T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25553,76306</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220117&DB=EPODOC&CC=PL&NR=3150198T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VERWIJS, MARINUS JACOBUS</creatorcontrib><creatorcontrib>ALARGOVA, ROSSITZA GUEORGUIEVA</creatorcontrib><creatorcontrib>KADIYALA, IRINA NIKOLAEVNA</creatorcontrib><creatorcontrib>KAUSHIK, RITU ROHIT</creatorcontrib><creatorcontrib>YOUNG, CHRISTOPHER RYAN</creatorcontrib><title>PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF</title><description>A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjsFqAjEURWfjotj-Q9yN4IPOBMUuny8Z5kGSFzIRHEVESrqSVrCf1A9tLf2ALg53c7ich-or9pg8kt1mJnSKxEcZOLOEQUmnNNQrqBuo20ULhju3lSQbG_ZyMMdDs9BHw7ITB0sY3VzRSE5ikojBEqaN7NCzkTlo8Db3o4tjYjEcoL37v0dMComNwvCD8Rx4yAnvBSr3NlnpHqvJ2_lyK09_O61mnc3UQ7l-nMrten4t7-XzFJ1uls_Nyzpnrf_jfAM5qEYc</recordid><startdate>20220117</startdate><enddate>20220117</enddate><creator>VERWIJS, MARINUS JACOBUS</creator><creator>ALARGOVA, ROSSITZA GUEORGUIEVA</creator><creator>KADIYALA, IRINA NIKOLAEVNA</creator><creator>KAUSHIK, RITU ROHIT</creator><creator>YOUNG, CHRISTOPHER RYAN</creator><scope>EVB</scope></search><sort><creationdate>20220117</creationdate><title>PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF</title><author>VERWIJS, MARINUS JACOBUS ; ALARGOVA, ROSSITZA GUEORGUIEVA ; KADIYALA, IRINA NIKOLAEVNA ; KAUSHIK, RITU ROHIT ; YOUNG, CHRISTOPHER RYAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3150198TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>VERWIJS, MARINUS JACOBUS</creatorcontrib><creatorcontrib>ALARGOVA, ROSSITZA GUEORGUIEVA</creatorcontrib><creatorcontrib>KADIYALA, IRINA NIKOLAEVNA</creatorcontrib><creatorcontrib>KAUSHIK, RITU ROHIT</creatorcontrib><creatorcontrib>YOUNG, CHRISTOPHER RYAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VERWIJS, MARINUS JACOBUS</au><au>ALARGOVA, ROSSITZA GUEORGUIEVA</au><au>KADIYALA, IRINA NIKOLAEVNA</au><au>KAUSHIK, RITU ROHIT</au><au>YOUNG, CHRISTOPHER RYAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF</title><date>2022-01-17</date><risdate>2022</risdate><abstract>A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; pol
recordid	cdi_epo_espacenet_PL3150198TT3
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T08%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VERWIJS,%20MARINUS%20JACOBUS&rft.date=2022-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3150198TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true